US FDA issues new safety warning for certain antibiotics

21 December 2018
fda_big

Following a review of fluoroquinolone antibiotics, the US Food and Drug Administration has issued a statement regarding an association with a rare but serious side effect.

The agency says use of the antibiotic is linked with ruptures or tears in the aorta which can lead to dangerous bleeding and death. They can occur with fluoroquinolones for systemic use given by mouth or through an injection.

Fluoroquinolone antibiotics, which are approved to treat certain bacterial infections, have been used for decades. They work by killing or stopping the growth of bacteria.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical